Ledger.Open graph →

SEC Form D · Amendment · filed April 11, 2025

Alger Life Sciences Innovation Fund LP

Offering

—

Sold

$17.3M

Exemption

Rule 506(b)

Industry

Pooled Investment Fund

Location

NEW YORK, NY

Type

Pooled fund

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Hal C. Liebes · New York, NYExec · Director Robert L. Kincel · New York, NYExec · Director Daniel C. Chung · New York, NYExec · Director Alger Alternative Holdings Ii, Llc · New York, NYPromoter Burton M. Tripathi, Ph.D · Goleta, CAExec · Director Brian M. Clark · Goleta, CAExec · Director Robert Reali · Goleta, CAExec · Director Alger Alternative Holdings Ii, Llc · New York, NYPromoter Fred Alger Management, Llc · New York, NYPromoter Lauren S. Thomas Compton · Tampa, FLExec · Director Jeff S. Currie · Portland, ORExec · Director Venkataraman K. Tiruppayanamh · Portland, ORExec · Director Alger Alternative Holdings Ii, Llc · New York, NYPromoter Fred Alger Management, Llc · New York, NYPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗